Skip to main content
HR 5775 115th Congress House Health Administrative law and regulatory procedures Alternative treatments Consumer affairs Department of Health and Human Services Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Government information and archives Health care costs and insurance Health care quality Health information and medical records Health personnel Home and outpatient care Hospital care Medicare Prescription drugs Solid waste and recycling

PROPER Act of 2018

Introduced: May 11, 2018 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 15 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 20, 2018
Received in the Senate and Read twice and referred to the Committee on Finance.
Jun 19, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jun 19, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5256-5257)
Jun 19, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5256-5257)
Jun 19, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 5775.
Jun 19, 2018
Considered under suspension of the rules. (consideration: CR H5256-5258)
Jun 19, 2018
Mr. Curbelo (FL) moved to suspend the rules and pass the bill, as amended.
Jun 19, 2018
Placed on the Union Calendar, Calendar No. 594.
Jun 19, 2018
Committee on Energy and Commerce discharged.
Jun 19, 2018
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-763, Part I.
Jun 4, 2018
Referred to the Subcommittee on Health.
May 16, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 16, 2018
Committee Consideration and Mark-up Session Held.
May 11, 2018
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 11, 2018
Introduced in House
 Plain-English summary Congressional Research Service

Providing Reliable Options for Patients and Educational Resources Act of 2018 or the PROPER Act of 2018

(Sec. 2) This bill requires Medicare and Medicare Advantage (MA) prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the risks of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).

(Sec. 3) The bill also requires Medicare medication therapy management programs and MA in-home health risk assessments to include information about the safe disposal of prescription drugs.

(Sec. 4) The bill prohibits inclusion of pain management questions in certain health care system surveys, unless the questions address the risks of opioid use and the availability of non-opioid alternatives.

What's happening now June 20, 2018

Received in the Senate and Read twice and referred to the Committee on Finance.

 Committees of jurisdiction 4
 Cosponsors 1
All 1 Republican 1